Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 2/20 | 0.32 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | GLA | P06280 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | NQO1 | P15559 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL653627 | 0.94 | NQO1 (0.33) | ESR1ESR2KDM4EGLAMAPT | |
| SCHEMBL650019 | 0.85 | CYP1A2 (0.32) | ESR1ESR2KDM4EGLAMAPT | |
| SCHEMBL652937 | 0.83 | NQO1 (0.38) | KDM4EMAPTKMT2ACYP1A2CYP2C19 | |
| SCHEMBL649394 | 0.79 | NQO1 (0.32) | NQO1 | |
| SCHEMBL651788 | 0.78 | ESR1 (0.33) | ESR1ESR2KDM4EGLAKMT2A | |
| SCHEMBL651813 | 0.78 | NQO1 (0.35) | ESR1ESR2KDM4EGLAMAPT | |
| SCHEMBL656268 | 0.77 | ELANE (0.37) | ESR1ESR2KDM4EGLAMAPT | |
| SCHEMBL650726 | 0.75 | ELANE (0.33) | ESR1ESR2KDM4EGLAMAPT | |
| SCHEMBL653077 | 0.75 | NQO1 (0.37) | KDM4EMAPTKMT2ACYP1A2CYP2C19 | |
| SCHEMBL3440746 | 0.75 | NQO1 (0.42) | KDM4EGLAMAPTKMT2ACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8119804-B2 | Organic semiconducting layers | MERCK PATENT GMBH (DE) | 2012-02-21 | — | — | US | disclosed |
| US-7842942-B2 | Organic semiconducting layers | MERCK PATENT GMBH (DE) | 2010-11-30 | — | — | US | disclosed |
| US-7807993-B2 | Organic pentacene semiconducting layers | MERCK PATENT GMBH (DE) | 2010-10-05 | — | — | US | disclosed |
| US-20100227956-A1 | Organic Semiconducting Layers | FLEXENABLE TECHNOLOGY LIMITED (GB) | 2010-09-09 | — | — | US | disclosed |
| EP-1687830-B1 | ORGANIC SEMICONDUCTING LAYER FORMULATIONS COMPRISING POLYACENES AND ORGANIC BINDER POLYMERS | MERCK PATENT GMBH (DE) | 2010-07-28 | — | — | EP | disclosed |
| US-7576208-B2 | Organic semiconductor layers | MERCK PATENT GMBH (DE) | 2009-08-18 | — | — | US | disclosed |
| US-20080009625-A1 | 6,13-bis(triisopropylsilylethynyl)pentacene, use in in various electronic devices and in a formulation for ink jet printing and in an organic field effect transistors | FLEXENABLE TECHNOLOGY LIMITED (GB) | 2008-01-10 | — | — | US | disclosed |
| EP-1808866-A1 | Organic semiconducting layer formulations comprising polyacenes and organic binder polymers | Merck Patent GmbH (DE) | 2007-07-18 | — | — | EP | disclosed |
| US-20070137520-A1 | ORGANIC SEMICONDUCTING LAYERS | FLEXENABLE TECHNOLOGY LIMITED (GB) | 2007-06-21 | — | — | US | disclosed |
| US-20070102696-A1 | Organic semiconducting layers | FLEXENABLE TECHNOLOGY LIMITED (GB) | 2007-05-10 | — | — | US | disclosed |
| EP-1783781-A2 | ORGANIC SEMICONDUCTING LAYER FORMULATIONS COMPRISING POLYACENES AND ORGANIC BINDER POLYMERS | Merck Patent GmbH (DE) | 2007-05-09 | — | — | EP | disclosed |
| EP-1687830-A2 | ORGANIC SEMICONDUCTING LAYER FORMULATIONS COMPRISING POLYACENES AND ORGANIC BINDER POLYMERS | Merck Patent GmbH (DE) | 2006-08-09 | — | — | EP | disclosed |
| WO-2005055248-A2 | ORGANIC SEMICONDUCTING LAYER FORMULATIONS COMPRISING POLYACENES AND ORGANIC BINDER POLYMERS | MERCK PATENT GMBH (DE) | 2005-06-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080009625-A1 | 6,13-bis(triisopropylsilylethynyl)pentacene, use in in various electronic devices and in a formulation for ink jet printing and in an organic field effect transistors | OR10J3, RCOR3, H1-10 | ESR1 1205/4885ESR2 1517/4885KDM4E 1142/4885 |
| US-20070102696-A1 | Organic semiconducting layers | SSB, RCOR3, CNKSR1 | ESR1 1081/4885ESR2 413/4885KDM4E 2519/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.